CERUS ENDOVASCULAR LTD has a total of 27 patent applications. It decreased the IP activity by 16.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets medical technology are G UCHREZHDENIE ZDRAVOOKHRANENIJA NII SKOROJ POMOSHCHI IM N V SKLIFOSOVSKOGO DEPARTAMENTA ZDRAVOOKHRA, S & T MARKETING AG and EZISURG MEDICAL CO LTD.
| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Canada | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | China | 3 | |
| #6 | Israel | 1 | |
| #7 | Japan | 1 | |
| #8 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Diagnosis and surgery |
| # | Name | Total Patents |
|---|---|---|
| #1 | Griffin Stephen | 24 |
| #2 | Stephen Griffin | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN111278367A | Blocking device | |
| EP3782576A1 | Occlusion device | |
| EP3386402A2 | Occlusion device | |
| CN106456183A | Occlusion device |